Relapsed Disease

Relapsed Disease is a disease status in hematologic oncology characterized by the reappearance of clinically or measurably detectable malignant cells after having previously achieved a complete remission following initial therapy.

5.2K

Publications

336.6K

Citations

30.2K

Authors

4.7K

Institutions

Publications per year

2017–2026

1.5K

Authors

30.2K

  1. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    105 publications · 9.8K citations

    46

    h-index

  2. FR
    Farhad Ravandi

    The University of Texas MD Anderson Cancer Center, United States

    61 publications · 3.6K citations

    33

    h-index

  3. SJ
    Sundar Jagannath

    Dana-Farber Cancer Institute, United States

    55 publications · 6.3K citations

    32

    h-index

  4. MΑ
    Meletios Α. Dimopoulos

    National and Kapodistrian University of Athens, Greece

    54 publications · 6.9K citations

    31

    h-index

  5. PM
    Philippe Moreau

    Centre Hospitalier Universitaire de Nantes, France

    62 publications · 9K citations

    31

    h-index

1–5 of 30.2K

Venues

  1. Blood

    761 publications · 54.6K citations

    125

    h-index

  2. Journal of Clinical Oncology

    306 publications · 39K citations

    111

    h-index

  3. Leukemia

    136 publications · 12.9K citations

    67

    h-index

  4. Cancer

    193 publications · 11.2K citations

    63

    h-index

  5. British Journal of Haematology

    BJH · 188 publications · 9.4K citations

    59

    h-index

1–5